231 related articles for article (PubMed ID: 22309237)
1. Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics.
Kouodom MN; Ronconi L; Celegato M; Nardon C; Marchiò L; Dou QP; Aldinucci D; Formaggio F; Fregona D
J Med Chem; 2012 Mar; 55(5):2212-26. PubMed ID: 22309237
[TBL] [Abstract][Full Text] [Related]
2. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
Kouodom MN; Boscutti G; Celegato M; Crisma M; Sitran S; Aldinucci D; Formaggio F; Ronconi L; Fregona D
J Inorg Biochem; 2012 Dec; 117():248-60. PubMed ID: 22877925
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations.
Boscutti G; Nardon C; Marchiò L; Crisma M; Biondi B; Dalzoppo D; Dalla Via L; Formaggio F; Casini A; Fregona D
ChemMedChem; 2018 Jun; 13(11):1131-1145. PubMed ID: 29570944
[TBL] [Abstract][Full Text] [Related]
4. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
Giovagnini L; Ronconi L; Aldinucci D; Lorenzon D; Sitran S; Fregona D
J Med Chem; 2005 Mar; 48(5):1588-95. PubMed ID: 15743200
[TBL] [Abstract][Full Text] [Related]
6. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.
Rubbiani R; Can S; Kitanovic I; Alborzinia H; Stefanopoulou M; Kokoschka M; Mönchgesang S; Sheldrick WS; Wölfl S; Ott I
J Med Chem; 2011 Dec; 54(24):8646-57. PubMed ID: 22039997
[TBL] [Abstract][Full Text] [Related]
8. Structure--activity relationship and mode of action of N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters: novel organometallic anticancer compounds.
Mooney A; Tiedt R; Maghoub T; O'Donovan N; Crown J; White B; Kenny PT
J Med Chem; 2012 Jun; 55(11):5455-66. PubMed ID: 22548380
[TBL] [Abstract][Full Text] [Related]
9. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D
J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581
[TBL] [Abstract][Full Text] [Related]
10. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
11. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
13. Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines.
O'Connor M; Kellett A; McCann M; Rosair G; McNamara M; Howe O; Creaven BS; McClean S; Kia AF; O'Shea D; Devereux M
J Med Chem; 2012 Mar; 55(5):1957-68. PubMed ID: 22313179
[TBL] [Abstract][Full Text] [Related]
14. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
15. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
16. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
[TBL] [Abstract][Full Text] [Related]
17. Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts.
Celegato M; Fregona D; Mongiat M; Ronconi L; Borghese C; Canzonieri V; Casagrande N; Nardon C; Colombatti A; Aldinucci D
Future Med Chem; 2014 Jul; 6(11):1249-63. PubMed ID: 25162999
[TBL] [Abstract][Full Text] [Related]
18. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes.
Khan H; Badshah A; Murtaz G; Said M; Rehman ZU; Neuhausen C; Todorova M; Jean-Claude BJ; Butler IS
Eur J Med Chem; 2011 Sep; 46(9):4071-7. PubMed ID: 21724304
[TBL] [Abstract][Full Text] [Related]
20. Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).
Katsoulakou E; Tiliakos M; Papaefstathiou G; Terzis A; Raptopoulou C; Geromichalos G; Papazisis K; Papi R; Pantazaki A; Kyriakidis D; Cordopatis P; Manessi-Zoupa E
J Inorg Biochem; 2008 Jul; 102(7):1397-405. PubMed ID: 18289688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
